Egyt Gyogyszervegyeszeti Gyar

Egis Gyogyszergyar

Other

Basf Aktiengesellschaft

Richter Gedeon Vegyeszeti Gyar Rt

Egis Gyogyszergyar Rt.

Egis Gyogyszergyat

Edyt Gyogyszervegyeszeti Gyar

Lujza E Petocz

Ibolya Kosoczky

Katalin Grasser

Eniko Szirt Nee Kiszelly

Gabor Gigler

Zoltan Budai

Marton Fekete

Istvan Gacsalyi

Tibor Mezei

Pal Benko

Istvan Gyertyan

Gyorgy Hajos

Andras Messmer

Aranka Lay Nee Konya

Laszlo Pallos

Peter Gorog

Attila Mandi

Frigyes Gorgenyi

Klara Reiter Nee Esses

Edit Berenyi Nee Poldermann

Maria Szecsey Nee Hegedus

Sandor Batori

Jozsef Reiter

Eniko Kiszelly

Jozsef Knoll

Berta Knoll

Laszlo Rozsa

Jozsef Barkoczy

Peter Tompe

Laszlo Pongo

Laszlo Kapolnai

Gyula Simig

Jozsef Nagy

Katalin Szemeredi

Karoly Lempert

Gyula Hornyak

Jozsef Fetter

Ivan Beck

Istvan Simonyi

Gizella Zsila

Andras Dietz

Agnes Kovacs Nee Palotai

Laszlo Magdanyi

Elemer Jakfalvi

Endre Rivo

Katalin Budai Nee Simonyi

Zsuzsa Furts

Gabriella Zsila

Ildiko Niklya

Julia Timar

Zsuzsanna Orr

Maria Hegedus

Valeria Hoffmann

Antal Feller

Gabriella Zsilla

Gabor Blasko

Daniel Bozsing

Ferenc Lorant Bartha

Karoly Zauer

Gabor Doleschall

Jozsef Nyitrai

Laszlo Varga

Laszlo Levai

Gyula Mikite

Eva Furdyga

Gabor Fazekas

Katalin Zukovics Nee Sumeg

Gabriella Rmos Nee Lassu

Klara Gado

Edit Nee Berenyi

Josef Reiter

Josef Barkoczy

Aniko Kovacs

Katain Budainee Simonyi

Laszlo Kosa

Attila Varga

Agnes Koracs Nee Palotay

Andras Gelleri

Iboly Kosoczky

Ibolya Kasoczky

Eva Toncsev, Nee Ravasz

Gyo/ Rgyi Kovanyi

Judit Nee Timar

Peter Go/ Ro/ G

Hristone Toncsev

Eniko Nee Szirt

Zsuzsa Juhasz Nee Riedl

Maria Nee Sigmond

Grasser Katalin

Peter Huszthy

Eniko Szirt

Etelka Pjeczka

Laszlo Ladanyi

Eva Hartai Nee Zsorzs

Eniko Sziri neKiszelly

Katalin Sumeg Nee Zukovics

Istvan Gertyan

Edit Berenyi Ne Poldermann

Ne Simonyi Budai

Klara Gaso

The invention refers to a pharmaceutical composition, a process for the preparation thereof and a novel medical use of bicycloheptane derivatives. The pharmaceutical compositions of the invention comprise a bicycloheptane derivative of the formula I ##STR1## wherein said derivative is as defined in the specification herein. The pharmaceutical compositions of the invention are suitable for the treatment of diseases and disorders that are connected with the influence on the cholecystokinin system, especially for preventing the spastic contraction of the gallbladder.

Pharmaceutical compositions containing bicycloheptane ether amines and a

The invention relates to novel triazolyl thioamides of the general formula (I), ##STR1## wherein Q represents hydrogen or a heterocyclic group optionally bearing one or more C.sub.1-4 alkyl substituent(s), or a group of the formula SR.sup.1, wherein

Triazolyl thioamide derivates

The invention relates to new 2-(substituted imino)-thiazolidines, a process for the preparation thereof, pharmaceutical compositions comprising the same, the use of the said 2-(substituted imino)thiazolidines for the treatment of diseases and for the preparation of pharmaceutical compositions suitable for the treatment of diseases. The new 2-(substituted imino)-thiazolidine derivatives provided by the present invention correspond to the general formula (I), ##STR1## wherein R.sup.1 and R.sup.2 each represent halogen, nitro, C.sub.1-4 alkoxy or C.sub.1-4 alkyl, which latter may optionally carry one or more halogen substituent(s),

2-(substituted imino)-thiazolidines and process for the preparation

The invention relates to novel racemic or optically active aminopropanol derivatives of formula I ##STR1## wherein R and R.sup.1 are independently hydrogen atom, halogen atom, lower alkoxy, or together represent a methylene dioxy group,

Aminopropanol derivatives, process for their preparation and

This invention relates to novel triazolyl hydrazide derivatives and a process for the preparation thereof. The new triazolyl hydrazide derivatives of the general formula (I). ##STR1## wherein Q represents hydrogen or a heterocyclic group optionally substituted by a C.sub.1-4 alkyl group; or a group of general formula SR.sup.1, wherein

Triazolyl hydrazide derivatives

This invention relates to novel triazolo derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said triazolo derivatives for the treatment of diseases and also for the preparation of pharmaceutical compositions suitable for the treatment of the said diseases. The new triazolo derivatives of the general formulae (Ia) and (Ib), ##STR1## wherein Q represents hydrogen or a heterocyclic group optionally bearing one or more C.sub.1-4 alkyl substituent(s); or a group of the formula SR.sup.1, wherein

Triazolo derivatives and process for their preparation

The invention relates to new dihydropyrimidothiazine derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same and new intermediates useful in the preparation of the said dihydropyrimidothiazine derivatives.

Dihydropyrimidothiazine derivatives

This invention relates to novel triazolopyrimidine derivatives of formulae (Ia) and (Ib), ##STR1## wherein Q represents hydrogen, a heterocyclic group optionally substituted by a C.sub.1-4 alkyl group and containing one or more oxygen and/or nitrogen atoms or a group of formula

Novel triazolo-pyrimidine derivatives

The new compounds of the general Formula I ##STR1## (wherein R.sub.1 stands for C.sub.1-4 alkyl or aralkyl; and

Condensed quinolinium and isoquinolinium derivatives

Dioxazocine derivatives, their preparation and composition containing them, said derivatives being represented by the formula I ##STR1## wherein R.sub.1 represents hydrogen or alkyl having from 1 to 4 carbon atoms,

Dioxazocine derivatives compositions and methods containing them having

The new compounds of the general Formula I ##STR1## (wherein A stands for a C.sub.2-4 straight or branched chain alkylene group;

Substituted styrene derivatives

The 3-amino-4-ethylthio-quinoline of the Formula I ##STR1## and pharmaceutically acceptable acid addition salts thereof possess useful therapeutical properties. They exhibit a potent and highly selective anxiolytic and narcosis potentiating effect and are devoid of sedative and anti-convulsive effect. Consequently, the invention relates to pharmaceutical compositions comprising the compound of Formula I or a salt thereof as active agent. The invention also relates to a new and improved process for the preparation of the compound of Formula I.

Pharmaceutical compositions

The new compounds of the general Formula I ##STR1## (wherein R.sub.1 stands for C.sub.1-5 alkyl, C.sub.2-5 alkenyl, C.sub.2-5 alkinyl, C.sub.3-7 cycloalkyl or optionally substituted phenyl-(C.sub.1-4 alkyl);

Quinoline thioethers

Growing community of inventors

Budapest, Hungary

Lujza E Petocz